These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma. Kalmadi SR; Hussein MA Acta Haematol; 2006; 116(1):1-7. PubMed ID: 16809883 [TBL] [Abstract][Full Text] [Related]
5. New treatments for multiple myeloma. Richardson PG; Schlossman R; Hideshima T; Anderson KC Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632 [TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma: the role of transplant and novel treatment strategies. Kaufman J; Lonial S Semin Oncol; 2004 Apr; 31(2 Suppl 4):99-105. PubMed ID: 15124142 [TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in multiple myeloma. Chng WJ; Lau LG; Yusof N; Mow BM Cancer Control; 2005 Apr; 12(2):91-104. PubMed ID: 15855892 [TBL] [Abstract][Full Text] [Related]
8. Therapy strategies for multiple myeloma: current status. Gisslinger H; Kees M Wien Klin Wochenschr; 2003 Aug; 115(13-14):451-61. PubMed ID: 13677263 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis and the current trends in multiple myeloma therapy. Dmoszyńska A Pol Arch Med Wewn; 2008 Oct; 118(10):563-6. PubMed ID: 19112817 [TBL] [Abstract][Full Text] [Related]